[1] Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia[J].Blood,1991,78(12):3269-3274. [2] 周小鸽,陈辉树.造血与淋巴组织肿瘤WHO分类[M].北京:诊断病理学杂志社,2011:497-499. [3] Dungarwalla M,Matutes E,Dearden CE.Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper[J].Eur J Haematol,2008,80(6):469-476. [4] Kameoka J,Takahashi N,Noji H,et al.T-cell prolymphocytic leukemia in Japan:is it a variant[J]. Int J Hematol,2012,95(6):660-667. [5] Hoyer JD,Ross CW,Li CY,et al.True T-cell chronic lymphocytic leukemia:a morphologic and immunophenotypic study of 25 cases[J].Blood,1995,86(3):1163-1169. [6] Khot A,Dearden C.T-cell prolymphocytic leukemia[J].Expert Rev Anticancer Ther, 2009,9(3):365-371. [7] Alduaij A,Treaba DO,Winer ES.CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemia[J].Clin Lymphoma Myeloma Leuk,2011,11(1):64-67. [8] Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours hacmatopoictic and lymphoid tissuers[M].Lyon:IARC Press,2008: 312-319. [9] 唐雪峰,张国勇,王亚丽,等.ALK阴性的间变性大细胞淋巴瘤1例[J].诊断病理学杂志, 2010, 17(3): 237-238. [10] 李金范,李甘地,刘卫平,等.间变性大细胞淋巴瘤组织间变性淋巴瘤激酶及survivin 蛋白表达及其临床意义[J]. 中华病理学杂志,2006,35(4):213-217. [11] 王 娜, 谢守军, 武英伟,等.间变性大细胞淋巴瘤骨髓侵犯的临床病理特点[J]. 检验医学, 2009,24(8): 591-594. |